ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation.

James I Andorko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.